By Tiffany Hu ( November 22, 2019, 7:30 PM EST) -- The Federal Circuit affirmed Friday that a Johnson & Johnson subsidiary's blood-glucose test trips did not infringe two patents owned by a medical device maker, siding with a lower court that said the device maker had narrowed the claims that could have covered J&J's test strips during prosecution of its own patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.